The Top 100 Healthcare Leaders 2024 for the Middle East and North Africa (MENA) region include two women and two Tunisian companies, according to Forbes magazine.
According to Fortune Business Insights, MENA’s healthcare services market stood at $226.97 billion in 2023 and is projected to grow to $241.13 billion this year, reaching $412.25 billion by 2032.
And in 52nd place, Ms Sara Masmoudi, representing the Kilani Group. It fears the press and communication in general and gives very little information about the group’s financial health or even its business. It went so far as to withdraw one of his latest acquisitions from the Tunis stock exchange, where Adwya publishes its financial statements.
Ranked 92nd on the Forbes list for the MENA region, Ms Olfa Gam represents Cytopharma, which describes itself as ‘the first pharmaceutical company in the Africa & Middle East region dedicated entirely to the manufacture and marketing of generic cytotoxic drugs’.
Established in Tunisia in 2011, Cytopharma’s mission is to provide high quality, affordable oncology medicines to cancer patients around the world’.
Like the Kilani group, Cytopharma follows the ‘live hidden, live happy’ approach and no financial information is available.
